XML 52 R41.htm IDEA: XBRL DOCUMENT v3.25.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Jul. 07, 2017
Net income (loss) $ (4,477,000) $ (3,403,000)  
Cash used in operations 1,440,000 3,599,000  
Cash and cash equivalents 665,000    
Accumulated deficit (54,302,991) (49,826,229)  
Recognize revenue 211,724 0  
Allowance for sales returns 227,000 128,390  
Inventory Reserve 1,100,000 95,000  
Warranty Reserve 30,000 30,000  
Advertising And Promotional Expenses 221,000 498,000  
Research And Development Expenses 291,000 $ 492,000  
Cash Balances At Financial Institutions $ 250,000    
Shares of common stock outstanding 20,015,205 19,923,955  
Common Stock, Shares Authorized 250,000,000 250,000,000  
Convertible debentures      
Potentially Dilutive Securities 2,080,000 2,080,000  
Stock Options      
Potentially Dilutive Securities 805,042 617,542  
Preferred A stock      
Potentially Dilutive Securities 63,750 63,750  
2016 Equity Incentive Plan      
Shares of common stock outstanding 5,700,000 5,500,000  
Common Stock, Shares Authorized     2,000,000
2016 Equity Incentive Plan | Director [Member]      
Common Stock, Shares Issued 60,000 60,000  
Two Vendors | Accounts Payable      
Concentration Risk, Percentage   59.00%  
Two Vendors | Cost of Sales [Member]      
Concentration Risk, In Percentage 67.00% 70.00%  
One Vendors | Accounts Payable      
Concentration Risk, Percentage 60.00%    
Warrants      
Potentially Dilutive Securities 2,765,846 2,772,096